

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 5.09672396 |
| 2 | proteasome assembly (GO:0043248) | 4.63168553 |
| 3 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.26015622 |
| 4 | signal peptide processing (GO:0006465) | 4.18828840 |
| 5 | cullin deneddylation (GO:0010388) | 4.11253261 |
| 6 | protein deneddylation (GO:0000338) | 3.90814846 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 3.82067590 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82067590 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.78422676 |
| 10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.72678007 |
| 11 | protein localization to endosome (GO:0036010) | 3.66723351 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.66381151 |
| 13 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.60836523 |
| 14 | lysine metabolic process (GO:0006553) | 3.57541274 |
| 15 | lysine catabolic process (GO:0006554) | 3.57541274 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.56892447 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 3.56892447 |
| 18 | cysteine metabolic process (GO:0006534) | 3.56542264 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.56476128 |
| 20 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.56203192 |
| 21 | DNA deamination (GO:0045006) | 3.52853811 |
| 22 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.51223004 |
| 23 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.47466168 |
| 24 | negative regulation of ligase activity (GO:0051352) | 3.47466168 |
| 25 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.42417410 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.42417410 |
| 27 | platelet dense granule organization (GO:0060155) | 3.40401182 |
| 28 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.38921175 |
| 29 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.38921175 |
| 30 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.38921175 |
| 31 | lactate metabolic process (GO:0006089) | 3.35501559 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.32788330 |
| 33 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.31763773 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.21445609 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.20941642 |
| 36 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.20941642 |
| 37 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.19384757 |
| 38 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.19384757 |
| 39 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.17296669 |
| 40 | eosinophil chemotaxis (GO:0048245) | 3.17294667 |
| 41 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.16639064 |
| 42 | regulation of cellular amine metabolic process (GO:0033238) | 3.16116926 |
| 43 | ribosome assembly (GO:0042255) | 3.15205436 |
| 44 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.14814956 |
| 45 | glutamate metabolic process (GO:0006536) | 3.14390039 |
| 46 | drug transmembrane transport (GO:0006855) | 3.11011428 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10516668 |
| 48 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.09841893 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.09821801 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 3.08837996 |
| 51 | COPI coating of Golgi vesicle (GO:0048205) | 3.08837996 |
| 52 | branched-chain amino acid catabolic process (GO:0009083) | 3.04765987 |
| 53 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.04760288 |
| 54 | positive regulation of ligase activity (GO:0051351) | 3.03696416 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 2.98314433 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.98102956 |
| 57 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.97123377 |
| 58 | macroautophagy (GO:0016236) | 2.93633319 |
| 59 | amino acid salvage (GO:0043102) | 2.93250342 |
| 60 | L-methionine salvage (GO:0071267) | 2.93250342 |
| 61 | L-methionine biosynthetic process (GO:0071265) | 2.93250342 |
| 62 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.93099825 |
| 63 | sodium ion export (GO:0071436) | 2.90811385 |
| 64 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.88195427 |
| 65 | activation of protein kinase A activity (GO:0034199) | 2.87611542 |
| 66 | membrane budding (GO:0006900) | 2.87568025 |
| 67 | DNA double-strand break processing (GO:0000729) | 2.87411118 |
| 68 | fatty acid elongation (GO:0030497) | 2.84220869 |
| 69 | synaptic vesicle maturation (GO:0016188) | 2.81141675 |
| 70 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.80912769 |
| 71 | eosinophil migration (GO:0072677) | 2.80763832 |
| 72 | cytochrome complex assembly (GO:0017004) | 2.80420319 |
| 73 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.79888019 |
| 74 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.79888019 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 2.78011907 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 2.77374424 |
| 77 | sulfur amino acid catabolic process (GO:0000098) | 2.76106475 |
| 78 | protein carboxylation (GO:0018214) | 2.74939534 |
| 79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74939534 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 2.74447821 |
| 81 | succinate metabolic process (GO:0006105) | 2.74183452 |
| 82 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.73503963 |
| 83 | homocysteine metabolic process (GO:0050667) | 2.72522794 |
| 84 | transferrin transport (GO:0033572) | 2.71547927 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 2.71252502 |
| 86 | intracellular pH reduction (GO:0051452) | 2.70879129 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 2.70453269 |
| 88 | 4-hydroxyproline metabolic process (GO:0019471) | 2.69395781 |
| 89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.69267264 |
| 90 | adenosine metabolic process (GO:0046085) | 2.69105771 |
| 91 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.68726170 |
| 92 | negative regulation of protein ubiquitination (GO:0031397) | 2.68014148 |
| 93 | respiratory electron transport chain (GO:0022904) | 2.67618255 |
| 94 | glyoxylate metabolic process (GO:0046487) | 2.65579220 |
| 95 | peptidyl-histidine modification (GO:0018202) | 2.65460358 |
| 96 | electron transport chain (GO:0022900) | 2.64866932 |
| 97 | kynurenine metabolic process (GO:0070189) | 2.62858442 |
| 98 | anterograde synaptic vesicle transport (GO:0048490) | 2.62816737 |
| 99 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62739400 |
| 100 | bile acid biosynthetic process (GO:0006699) | 2.62652641 |
| 101 | cellular potassium ion homeostasis (GO:0030007) | 2.62052114 |
| 102 | nerve growth factor signaling pathway (GO:0038180) | 2.61697911 |
| 103 | regulation of ligase activity (GO:0051340) | 2.61423897 |
| 104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.61374989 |
| 105 | drug catabolic process (GO:0042737) | 2.60764930 |
| 106 | intestinal epithelial cell development (GO:0060576) | 2.60392127 |
| 107 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.59532625 |
| 108 | trivalent inorganic cation transport (GO:0072512) | 2.59436750 |
| 109 | ferric iron transport (GO:0015682) | 2.59436750 |
| 110 | mannosylation (GO:0097502) | 2.58924270 |
| 111 | dicarboxylic acid catabolic process (GO:0043649) | 2.58522843 |
| 112 | protein complex biogenesis (GO:0070271) | 2.57624268 |
| 113 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.55651613 |
| 114 | serine family amino acid catabolic process (GO:0009071) | 2.55471301 |
| 115 | protein targeting to Golgi (GO:0000042) | 2.55317634 |
| 116 | negative regulation of fibrinolysis (GO:0051918) | 2.54907290 |
| 117 | tricarboxylic acid metabolic process (GO:0072350) | 2.54328335 |
| 118 | positive regulation of cell cycle arrest (GO:0071158) | 2.54145801 |
| 119 | positive regulation of actin filament depolymerization (GO:0030836) | 2.54026419 |
| 120 | phagosome maturation (GO:0090382) | 2.53717036 |
| 121 | protein maturation by protein folding (GO:0022417) | 2.52802524 |
| 122 | cytidine deamination (GO:0009972) | 2.52133918 |
| 123 | cytidine metabolic process (GO:0046087) | 2.52133918 |
| 124 | cytidine catabolic process (GO:0006216) | 2.52133918 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 2.52025219 |
| 126 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.51804919 |
| 127 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50852427 |
| 128 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50852427 |
| 129 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.49772813 |
| 130 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.48744460 |
| 131 | protein K11-linked ubiquitination (GO:0070979) | 2.47898405 |
| 132 | tricarboxylic acid cycle (GO:0006099) | 2.47783928 |
| 133 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.47776867 |
| 134 | C-terminal protein lipidation (GO:0006501) | 2.47149039 |
| 135 | layer formation in cerebral cortex (GO:0021819) | 2.46628561 |
| 136 | positive regulation of glycolytic process (GO:0045821) | 2.46564997 |
| 137 | COPII vesicle coating (GO:0048208) | 2.45955414 |
| 138 | urate metabolic process (GO:0046415) | 2.45766278 |
| 139 | ketone body metabolic process (GO:1902224) | 2.44743702 |
| 140 | positive regulation of nuclease activity (GO:0032075) | 2.44699179 |
| 141 | regulation of protein glycosylation (GO:0060049) | 2.44437253 |
| 142 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.44125050 |
| 143 | endoplasmic reticulum organization (GO:0007029) | 2.43705731 |
| 144 | vesicle coating (GO:0006901) | 2.43155475 |
| 145 | rRNA modification (GO:0000154) | 2.42977065 |
| 146 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.42720841 |
| 147 | potassium ion import (GO:0010107) | 2.42423716 |
| 148 | regulation of ARF protein signal transduction (GO:0032012) | 2.41265916 |
| 149 | urea metabolic process (GO:0019627) | 2.40926741 |
| 150 | urea cycle (GO:0000050) | 2.40926741 |
| 151 | bile acid metabolic process (GO:0008206) | 2.40888038 |
| 152 | establishment of protein localization to Golgi (GO:0072600) | 2.40127154 |
| 153 | purine-containing compound salvage (GO:0043101) | 2.39893199 |
| 154 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.38316470 |
| 155 | locomotory exploration behavior (GO:0035641) | 2.38135313 |
| 156 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.37817611 |
| 157 | transcription from mitochondrial promoter (GO:0006390) | 2.36693436 |
| 158 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36582171 |
| 159 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36497089 |
| 160 | exogenous drug catabolic process (GO:0042738) | 2.36303716 |
| 161 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.36229113 |
| 162 | high-density lipoprotein particle remodeling (GO:0034375) | 2.36200457 |
| 163 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.36052468 |
| 164 | peptidyl-cysteine modification (GO:0018198) | 2.35405708 |
| 165 | acyl-CoA biosynthetic process (GO:0071616) | 2.34401932 |
| 166 | thioester biosynthetic process (GO:0035384) | 2.34401932 |
| 167 | pH reduction (GO:0045851) | 2.33456368 |
| 168 | maturation of 5.8S rRNA (GO:0000460) | 2.32964170 |
| 169 | tyrosine metabolic process (GO:0006570) | 2.32452291 |
| 170 | glycerol ether metabolic process (GO:0006662) | 2.32233203 |
| 171 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.32229451 |
| 172 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.32170937 |
| 173 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.31714997 |
| 174 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.31689551 |
| 175 | complement activation, alternative pathway (GO:0006957) | 2.31318584 |
| 176 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.31113432 |
| 177 | C-terminal protein amino acid modification (GO:0018410) | 2.30299089 |
| 178 | plasma lipoprotein particle clearance (GO:0034381) | 2.30187012 |
| 179 | reverse cholesterol transport (GO:0043691) | 2.28645886 |
| 180 | regulation of protein activation cascade (GO:2000257) | 2.28418434 |
| 181 | alpha-amino acid catabolic process (GO:1901606) | 2.27023450 |
| 182 | acylglycerol catabolic process (GO:0046464) | 2.26592180 |
| 183 | neutral lipid catabolic process (GO:0046461) | 2.26592180 |
| 184 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.25752873 |
| 185 | positive regulation of lipid catabolic process (GO:0050996) | 2.25193079 |
| 186 | vesicle transport along microtubule (GO:0047496) | 2.24674435 |
| 187 | amino-acid betaine metabolic process (GO:0006577) | 2.24440179 |
| 188 | drug transport (GO:0015893) | 2.24284632 |
| 189 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.23949129 |
| 190 | cellular amino acid catabolic process (GO:0009063) | 2.23813332 |
| 191 | ER-nucleus signaling pathway (GO:0006984) | 2.22262289 |
| 192 | fatty acid homeostasis (GO:0055089) | 2.21351588 |
| 193 | response to mercury ion (GO:0046689) | 2.20671083 |
| 194 | regulation of fibrinolysis (GO:0051917) | 2.20112875 |
| 195 | phosphate ion transport (GO:0006817) | 2.19378080 |
| 196 | regulation of triglyceride catabolic process (GO:0010896) | 2.18600293 |
| 197 | fatty acid transmembrane transport (GO:1902001) | 2.18374433 |
| 198 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.18283503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.66419166 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.11882187 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68864164 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.57086234 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.51951166 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.27928366 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.06323120 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.03396841 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.85504649 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.65201530 |
| 11 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.64218442 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.50629883 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.36406125 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30459141 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30169052 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26676992 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24193446 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.24025229 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22764784 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17144381 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15909968 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.15266464 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13793493 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.11162536 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03277799 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95453906 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.95315456 |
| 28 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.88956172 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.84986383 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82090148 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78872203 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78672165 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75071616 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74550196 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73303467 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72117335 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.71225364 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66146980 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65655563 |
| 40 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.64804516 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63692596 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.59167298 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57838904 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57560660 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55115090 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55074922 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53749432 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50557963 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50331828 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50310914 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49307414 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48788537 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48490661 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48019245 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47282021 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47128828 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46813732 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46458179 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46446182 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.44909059 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44717811 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43819540 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38497149 |
| 64 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37649115 |
| 65 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.33046004 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32984444 |
| 67 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32762274 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32575449 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32495947 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31635379 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30270258 |
| 72 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.27664393 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26776656 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26530936 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26248869 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25163517 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25163517 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23929834 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23708972 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23226411 |
| 81 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22810480 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22031433 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21692842 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21635081 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20397692 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20351506 |
| 87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20284949 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19912391 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19445699 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18717102 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18535654 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18164368 |
| 93 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.17957832 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17867421 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.17771753 |
| 96 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17492537 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17027065 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16870018 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.16646127 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16619429 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16318203 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15738917 |
| 103 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15605338 |
| 104 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15605338 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12981797 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11502487 |
| 107 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11321070 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10554955 |
| 109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09767158 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08832757 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08747927 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08728305 |
| 113 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08171565 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08062681 |
| 115 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07709722 |
| 116 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07633159 |
| 117 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07245918 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07062844 |
| 119 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06909245 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06763962 |
| 121 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06714493 |
| 122 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06714493 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05846814 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05536772 |
| 125 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05386411 |
| 126 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05158330 |
| 127 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03231529 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02893351 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02113061 |
| 130 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01743411 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01636995 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01626660 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01448489 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01423986 |
| 135 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01274029 |
| 136 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01048809 |
| 137 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.99980927 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99386984 |
| 139 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99346652 |
| 140 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99207610 |
| 141 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.98910170 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98877264 |
| 143 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98705694 |
| 144 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98301207 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98253302 |
| 146 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97192574 |
| 147 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96716564 |
| 148 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.96509083 |
| 149 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96448178 |
| 150 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96301354 |
| 151 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.95798757 |
| 152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95203305 |
| 153 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94968083 |
| 154 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94968083 |
| 155 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94949203 |
| 156 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.94144177 |
| 157 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93841056 |
| 158 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.92046225 |
| 159 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91639650 |
| 160 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91269708 |
| 161 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91178124 |
| 162 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90665730 |
| 163 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90139600 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89346518 |
| 165 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89274471 |
| 166 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89139579 |
| 167 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88759739 |
| 168 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.88751084 |
| 169 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88408962 |
| 170 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88325217 |
| 171 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87878268 |
| 172 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87715467 |
| 173 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87713586 |
| 174 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87694491 |
| 175 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86843241 |
| 176 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86453715 |
| 177 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.85809410 |
| 178 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85379052 |
| 179 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84171449 |
| 180 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83835369 |
| 181 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83549999 |
| 182 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83506594 |
| 183 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83377362 |
| 184 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82512524 |
| 185 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.81935266 |
| 186 | AR_19668381_ChIP-Seq_PC3_Human | 0.81817738 |
| 187 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81647832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.65154616 |
| 2 | MP0005360_urolithiasis | 4.22300264 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.39405611 |
| 4 | MP0005365_abnormal_bile_salt | 3.08717610 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.01157722 |
| 6 | MP0003252_abnormal_bile_duct | 2.89714348 |
| 7 | MP0003195_calcinosis | 2.83444866 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.75389063 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58896506 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.49971829 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.49877105 |
| 12 | MP0004043_abnormal_pH_regulation | 2.40917438 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.37301314 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.31893999 |
| 15 | MP0005379_endocrine/exocrine_gland_phen | 2.30530572 |
| 16 | MP0003329_amyloid_beta_deposits | 2.17303576 |
| 17 | MP0005671_abnormal_response_to | 2.13206490 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.13202569 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.12514361 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.11379546 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.06828785 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.06165278 |
| 23 | MP0009840_abnormal_foam_cell | 2.02084458 |
| 24 | MP0009046_muscle_twitch | 1.99215321 |
| 25 | MP0006054_spinal_hemorrhage | 1.98547147 |
| 26 | MP0005332_abnormal_amino_acid | 1.97870988 |
| 27 | MP0004130_abnormal_muscle_cell | 1.92202635 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.91894283 |
| 29 | MP0009785_altered_susceptibility_to | 1.89504754 |
| 30 | MP0004270_analgesia | 1.89358408 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.88646388 |
| 32 | MP0006082_CNS_inflammation | 1.88142521 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.83144388 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.79417719 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.76830425 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.73740448 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.70516679 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.69802797 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.69619734 |
| 40 | MP0000604_amyloidosis | 1.69414180 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.63091404 |
| 42 | MP0002163_abnormal_gland_morphology | 1.62271980 |
| 43 | MP0005083_abnormal_biliary_tract | 1.59803428 |
| 44 | MP0003690_abnormal_glial_cell | 1.59251822 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.58775685 |
| 46 | MP0003186_abnormal_redox_activity | 1.56319316 |
| 47 | MP0003880_abnormal_central_pattern | 1.54933093 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.51835324 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.50666872 |
| 50 | MP0003868_abnormal_feces_composition | 1.47667345 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.47377968 |
| 52 | MP0009697_abnormal_copulation | 1.45211576 |
| 53 | MP0002736_abnormal_nociception_after | 1.45035770 |
| 54 | MP0000358_abnormal_cell_content/ | 1.42222012 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.42171420 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.41846106 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.40097977 |
| 58 | MP0000747_muscle_weakness | 1.39447687 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.38900842 |
| 60 | MP0003786_premature_aging | 1.38845696 |
| 61 | MP0008872_abnormal_physiological_respon | 1.38784109 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.37695008 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 1.36661681 |
| 64 | MP0000609_abnormal_liver_physiology | 1.36206031 |
| 65 | MP0003303_peritoneal_inflammation | 1.35386433 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.34795009 |
| 67 | MP0001984_abnormal_olfaction | 1.33197404 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.33002058 |
| 69 | MP0000685_abnormal_immune_system | 1.31223356 |
| 70 | MP0003283_abnormal_digestive_organ | 1.29057451 |
| 71 | MP0008058_abnormal_DNA_repair | 1.28161214 |
| 72 | MP0004885_abnormal_endolymph | 1.26826052 |
| 73 | MP0000003_abnormal_adipose_tissue | 1.26170894 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.25570222 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.23701107 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.23265364 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 1.22535646 |
| 78 | MP0001765_abnormal_ion_homeostasis | 1.21886440 |
| 79 | MP0003724_increased_susceptibility_to | 1.21677827 |
| 80 | MP0001905_abnormal_dopamine_level | 1.21211094 |
| 81 | MP0001529_abnormal_vocalization | 1.21115273 |
| 82 | MP0001853_heart_inflammation | 1.20836811 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.19725833 |
| 84 | MP0005535_abnormal_body_temperature | 1.18831358 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18573021 |
| 86 | MP0001764_abnormal_homeostasis | 1.18209337 |
| 87 | MP0003787_abnormal_imprinting | 1.18093630 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.17641657 |
| 89 | MP0001756_abnormal_urination | 1.16953350 |
| 90 | MP0003045_fibrosis | 1.15936022 |
| 91 | MP0005666_abnormal_adipose_tissue | 1.15898326 |
| 92 | MP0000343_altered_response_to | 1.15541734 |
| 93 | MP0003011_delayed_dark_adaptation | 1.15368020 |
| 94 | MP0004858_abnormal_nervous_system | 1.15047582 |
| 95 | MP0002254_reproductive_system_inflammat | 1.14171543 |
| 96 | MP0009764_decreased_sensitivity_to | 1.12394165 |
| 97 | MP0001845_abnormal_inflammatory_respons | 1.12064486 |
| 98 | MP0005375_adipose_tissue_phenotype | 1.11926785 |
| 99 | MP0002896_abnormal_bone_mineralization | 1.11425826 |
| 100 | MP0008004_abnormal_stomach_pH | 1.09653711 |
| 101 | MP0005387_immune_system_phenotype | 1.08403564 |
| 102 | MP0001790_abnormal_immune_system | 1.08403564 |
| 103 | MP0000372_irregular_coat_pigmentation | 1.07691286 |
| 104 | MP0000647_abnormal_sebaceous_gland | 1.07146707 |
| 105 | MP0003633_abnormal_nervous_system | 1.07143197 |
| 106 | MP0002693_abnormal_pancreas_physiology | 1.06856434 |
| 107 | MP0005253_abnormal_eye_physiology | 1.06478525 |
| 108 | MP0002272_abnormal_nervous_system | 1.05234974 |
| 109 | MP0001968_abnormal_touch/_nociception | 1.03568803 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 1.03233216 |
| 111 | MP0005310_abnormal_salivary_gland | 1.03049048 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 1.02798009 |
| 113 | MP0003950_abnormal_plasma_membrane | 1.01568870 |
| 114 | MP0000920_abnormal_myelination | 1.00728713 |
| 115 | MP0002638_abnormal_pupillary_reflex | 1.00456940 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.99296585 |
| 117 | MP0001919_abnormal_reproductive_system | 0.97419986 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.96966597 |
| 119 | MP0002928_abnormal_bile_duct | 0.95036146 |
| 120 | MP0005187_abnormal_penis_morphology | 0.94545681 |
| 121 | MP0000427_abnormal_hair_cycle | 0.94007927 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.93968998 |
| 123 | MP0002168_other_aberrant_phenotype | 0.93749949 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.93699661 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.93650456 |
| 126 | MP0002971_abnormal_brown_adipose | 0.92518582 |
| 127 | MP0008007_abnormal_cellular_replicative | 0.91569788 |
| 128 | MP0005165_increased_susceptibility_to | 0.91391006 |
| 129 | MP0003075_altered_response_to | 0.91332435 |
| 130 | MP0002090_abnormal_vision | 0.89254993 |
| 131 | MP0003634_abnormal_glial_cell | 0.88980242 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.88131925 |
| 133 | MP0004084_abnormal_cardiac_muscle | 0.87460180 |
| 134 | MP0002063_abnormal_learning/memory/cond | 0.86483744 |
| 135 | MP0002452_abnormal_antigen_presenting | 0.85918014 |
| 136 | MP0002102_abnormal_ear_morphology | 0.85893077 |
| 137 | MP0002723_abnormal_immune_serum | 0.85308703 |
| 138 | MP0000516_abnormal_urinary_system | 0.85127468 |
| 139 | MP0005367_renal/urinary_system_phenotyp | 0.85127468 |
| 140 | MP0002064_seizures | 0.85114126 |
| 141 | MP0003718_maternal_effect | 0.83297876 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.83067456 |
| 143 | MP0001661_extended_life_span | 0.82151859 |
| 144 | MP0002734_abnormal_mechanical_nocicepti | 0.80623805 |
| 145 | MP0005220_abnormal_exocrine_pancreas | 0.80617834 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.79821340 |
| 147 | MP0006276_abnormal_autonomic_nervous | 0.79157838 |
| 148 | MP0004957_abnormal_blastocyst_morpholog | 0.78253432 |
| 149 | MP0008873_increased_physiological_sensi | 0.76479081 |
| 150 | MP0001440_abnormal_grooming_behavior | 0.76326240 |
| 151 | MP0005166_decreased_susceptibility_to | 0.76269663 |
| 152 | MP0002006_tumorigenesis | 0.75788605 |
| 153 | MP0001727_abnormal_embryo_implantation | 0.75439100 |
| 154 | MP0010352_gastrointestinal_tract_polyps | 0.74646246 |
| 155 | MP0005636_abnormal_mineral_homeostasis | 0.73586630 |
| 156 | MP0003631_nervous_system_phenotype | 0.72601446 |
| 157 | MP0005334_abnormal_fat_pad | 0.72103626 |
| 158 | MP0002733_abnormal_thermal_nociception | 0.71955471 |
| 159 | MP0004264_abnormal_extraembryonic_tissu | 0.71764417 |
| 160 | MP0003953_abnormal_hormone_level | 0.68071418 |
| 161 | MP0002822_catalepsy | 0.67226802 |
| 162 | MP0002269_muscular_atrophy | 0.67103372 |
| 163 | MP0004087_abnormal_muscle_fiber | 0.66178277 |
| 164 | MP0004811_abnormal_neuron_physiology | 0.63819619 |
| 165 | MP0010678_abnormal_skin_adnexa | 0.63020121 |
| 166 | MP0002229_neurodegeneration | 0.62255890 |
| 167 | MP0009745_abnormal_behavioral_response | 0.61728289 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.61212637 |
| 169 | MP0004145_abnormal_muscle_electrophysio | 0.60843258 |
| 170 | MP0008874_decreased_physiological_sensi | 0.60127604 |
| 171 | MP0002136_abnormal_kidney_physiology | 0.59904198 |
| 172 | MP0003566_abnormal_cell_adhesion | 0.58972323 |
| 173 | MP0000598_abnormal_liver_morphology | 0.57173611 |
| 174 | MP0003632_abnormal_nervous_system | 0.56692716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.74856589 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.72225260 |
| 3 | Progressive macrocephaly (HP:0004481) | 3.58201611 |
| 4 | Xanthomatosis (HP:0000991) | 3.36886105 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.35932778 |
| 6 | Hypoglycemic coma (HP:0001325) | 3.32239449 |
| 7 | Ketoacidosis (HP:0001993) | 3.31964083 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.31877093 |
| 9 | Acute encephalopathy (HP:0006846) | 3.29061235 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.25585172 |
| 11 | Increased CSF lactate (HP:0002490) | 3.22247730 |
| 12 | Gout (HP:0001997) | 3.18721264 |
| 13 | Papilledema (HP:0001085) | 3.17166511 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.16745627 |
| 15 | Insidious onset (HP:0003587) | 3.11040874 |
| 16 | Termporal pattern (HP:0011008) | 3.11040874 |
| 17 | Methylmalonic acidemia (HP:0002912) | 3.08336316 |
| 18 | Abnormality of the anterior horn cell (HP:0006802) | 3.03209473 |
| 19 | Degeneration of anterior horn cells (HP:0002398) | 3.03209473 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.03079380 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.00832402 |
| 22 | Ketosis (HP:0001946) | 2.98020596 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 2.97688769 |
| 24 | Hypoglycemic seizures (HP:0002173) | 2.97297592 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.94666267 |
| 26 | Hyperglycinemia (HP:0002154) | 2.94563012 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 2.85396952 |
| 28 | Abnormal glycosylation (HP:0012345) | 2.85396952 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.85396952 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.85396952 |
| 31 | Hypokinesia (HP:0002375) | 2.85019833 |
| 32 | Hepatic necrosis (HP:0002605) | 2.78720696 |
| 33 | Methylmalonic aciduria (HP:0012120) | 2.78212748 |
| 34 | Neurofibrillary tangles (HP:0002185) | 2.72346560 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71659983 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.71659983 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 2.68669073 |
| 38 | Global brain atrophy (HP:0002283) | 2.67100567 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64555998 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63747195 |
| 41 | Hyperglycinuria (HP:0003108) | 2.63435880 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.62694070 |
| 43 | Hepatocellular necrosis (HP:0001404) | 2.61152393 |
| 44 | Hyperglycemia (HP:0003074) | 2.57489556 |
| 45 | Cerebral edema (HP:0002181) | 2.55949632 |
| 46 | Tongue fasciculations (HP:0001308) | 2.51750905 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.47772460 |
| 48 | Back pain (HP:0003418) | 2.46897345 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 2.44636096 |
| 50 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.44270244 |
| 51 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.44270244 |
| 52 | Neuroendocrine neoplasm (HP:0100634) | 2.43088716 |
| 53 | Lipid accumulation in hepatocytes (HP:0006561) | 2.42041811 |
| 54 | Hypoproteinemia (HP:0003075) | 2.41362186 |
| 55 | Visual hallucinations (HP:0002367) | 2.41244100 |
| 56 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.39459942 |
| 57 | Epidermoid cyst (HP:0200040) | 2.39291365 |
| 58 | Abnormality of vitamin B metabolism (HP:0004340) | 2.39152341 |
| 59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.39029556 |
| 60 | Palpitations (HP:0001962) | 2.37037096 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.36509675 |
| 62 | Abnormality of methionine metabolism (HP:0010901) | 2.35687561 |
| 63 | Supranuclear gaze palsy (HP:0000605) | 2.34717435 |
| 64 | Complement deficiency (HP:0004431) | 2.34058944 |
| 65 | Hypokalemic alkalosis (HP:0001949) | 2.33273771 |
| 66 | Hypothermia (HP:0002045) | 2.32665631 |
| 67 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.32652738 |
| 68 | Increased circulating renin level (HP:0000848) | 2.32584272 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 2.32015002 |
| 70 | Stomatitis (HP:0010280) | 2.30866113 |
| 71 | Lactic acidosis (HP:0003128) | 2.27232376 |
| 72 | Respiratory failure (HP:0002878) | 2.24753566 |
| 73 | Increased serum lactate (HP:0002151) | 2.23738386 |
| 74 | Skin nodule (HP:0200036) | 2.23563565 |
| 75 | Intention tremor (HP:0002080) | 2.23559583 |
| 76 | Increased serum pyruvate (HP:0003542) | 2.22759249 |
| 77 | Hypobetalipoproteinemia (HP:0003563) | 2.22688306 |
| 78 | Lethargy (HP:0001254) | 2.20691470 |
| 79 | Medial flaring of the eyebrow (HP:0010747) | 2.19925803 |
| 80 | Macroorchidism (HP:0000053) | 2.19215853 |
| 81 | Hyperammonemia (HP:0001987) | 2.18596080 |
| 82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18590295 |
| 83 | Action tremor (HP:0002345) | 2.18301835 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.18294447 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18294447 |
| 86 | Resting tremor (HP:0002322) | 2.15743566 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.14069172 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 2.13601310 |
| 89 | Conjunctival hamartoma (HP:0100780) | 2.09129134 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09008064 |
| 91 | Renal cortical cysts (HP:0000803) | 2.08953370 |
| 92 | CNS demyelination (HP:0007305) | 2.08528394 |
| 93 | Tetraparesis (HP:0002273) | 2.07012702 |
| 94 | Spastic diplegia (HP:0001264) | 2.06908243 |
| 95 | Muscle fibrillation (HP:0010546) | 2.06423123 |
| 96 | Cerebral hypomyelination (HP:0006808) | 2.05830414 |
| 97 | Generalized aminoaciduria (HP:0002909) | 2.04915313 |
| 98 | Increased CSF protein (HP:0002922) | 2.04764695 |
| 99 | Agitation (HP:0000713) | 2.02162281 |
| 100 | Symptomatic seizures (HP:0011145) | 2.01181574 |
| 101 | Hypoalphalipoproteinemia (HP:0003233) | 1.98704970 |
| 102 | Dysostosis multiplex (HP:0000943) | 1.97621154 |
| 103 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.96781396 |
| 104 | Hypolipoproteinemia (HP:0010981) | 1.95918110 |
| 105 | Hypomagnesemia (HP:0002917) | 1.95047775 |
| 106 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94936688 |
| 107 | Mitral stenosis (HP:0001718) | 1.94523086 |
| 108 | Metabolic alkalosis (HP:0200114) | 1.93067447 |
| 109 | Muscular hypotonia of the trunk (HP:0008936) | 1.92766268 |
| 110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.92291129 |
| 111 | Abnormality of glycolysis (HP:0004366) | 1.91818489 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90490404 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90490404 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90490404 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 1.90206948 |
| 116 | Glycosuria (HP:0003076) | 1.90206948 |
| 117 | Proximal tubulopathy (HP:0000114) | 1.90007825 |
| 118 | Neoplasm of the adrenal gland (HP:0100631) | 1.89933510 |
| 119 | Diminished movement (HP:0002374) | 1.89678282 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.89555083 |
| 121 | Hyperalaninemia (HP:0003348) | 1.89555083 |
| 122 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89555083 |
| 123 | Exercise intolerance (HP:0003546) | 1.87632414 |
| 124 | Subacute progressive viral hepatitis (HP:0006572) | 1.87603593 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.87427567 |
| 126 | Exertional dyspnea (HP:0002875) | 1.86989781 |
| 127 | Congenital primary aphakia (HP:0007707) | 1.86779461 |
| 128 | Chronic diarrhea (HP:0002028) | 1.85670841 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.85487967 |
| 130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85260695 |
| 131 | Postural tremor (HP:0002174) | 1.84488562 |
| 132 | Hepatocellular carcinoma (HP:0001402) | 1.84388240 |
| 133 | Achilles tendon contracture (HP:0001771) | 1.84049245 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83883266 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83883266 |
| 136 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83883266 |
| 137 | Urinary urgency (HP:0000012) | 1.83724787 |
| 138 | Spastic tetraparesis (HP:0001285) | 1.82690734 |
| 139 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.82168560 |
| 140 | Hyperuricemia (HP:0002149) | 1.82059413 |
| 141 | Increased purine levels (HP:0004368) | 1.82059413 |
| 142 | Leukodystrophy (HP:0002415) | 1.80870154 |
| 143 | Late onset (HP:0003584) | 1.80834856 |
| 144 | Myocardial infarction (HP:0001658) | 1.80069413 |
| 145 | Exercise-induced muscle cramps (HP:0003710) | 1.80039862 |
| 146 | Pheochromocytoma (HP:0002666) | 1.79358475 |
| 147 | Irritability (HP:0000737) | 1.78228548 |
| 148 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78213388 |
| 149 | Fat malabsorption (HP:0002630) | 1.77646649 |
| 150 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77211947 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.76975731 |
| 152 | Abnormality of placental membranes (HP:0011409) | 1.76447974 |
| 153 | Amniotic constriction ring (HP:0009775) | 1.76447974 |
| 154 | Hyporeflexia of lower limbs (HP:0002600) | 1.76219941 |
| 155 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76203023 |
| 156 | Dicarboxylic aciduria (HP:0003215) | 1.76203023 |
| 157 | Gait imbalance (HP:0002141) | 1.75920785 |
| 158 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75101746 |
| 159 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74979248 |
| 160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.74357824 |
| 161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.74357824 |
| 162 | Restlessness (HP:0000711) | 1.74111212 |
| 163 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73831987 |
| 164 | Protuberant abdomen (HP:0001538) | 1.73030127 |
| 165 | Alkalosis (HP:0001948) | 1.72702530 |
| 166 | Optic disc pallor (HP:0000543) | 1.72538143 |
| 167 | Abnormality of chloride homeostasis (HP:0011422) | 1.72249194 |
| 168 | Petechiae (HP:0000967) | 1.71964273 |
| 169 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.71640385 |
| 170 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71640385 |
| 171 | Amyotrophic lateral sclerosis (HP:0007354) | 1.70770212 |
| 172 | Turricephaly (HP:0000262) | 1.70529463 |
| 173 | Thyroid carcinoma (HP:0002890) | 1.69641922 |
| 174 | Hypokalemia (HP:0002900) | 1.69183652 |
| 175 | Abnormality of renal resorption (HP:0011038) | 1.68254700 |
| 176 | Delusions (HP:0000746) | 1.68163352 |
| 177 | Abnormality of serum amino acid levels (HP:0003112) | 1.67689519 |
| 178 | Poor suck (HP:0002033) | 1.67636628 |
| 179 | Polyphagia (HP:0002591) | 1.67066711 |
| 180 | Lymphangioma (HP:0100764) | 1.66485239 |
| 181 | Retinal atrophy (HP:0001105) | 1.65482557 |
| 182 | Myoglobinuria (HP:0002913) | 1.65238038 |
| 183 | Hyperkalemia (HP:0002153) | 1.64553111 |
| 184 | Difficulty running (HP:0009046) | 1.63731195 |
| 185 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63483751 |
| 186 | Neuronal loss in central nervous system (HP:0002529) | 1.63467055 |
| 187 | Bundle branch block (HP:0011710) | 1.63296954 |
| 188 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.63287820 |
| 189 | Impaired social interactions (HP:0000735) | 1.63094126 |
| 190 | Abnormal social behavior (HP:0012433) | 1.63094126 |
| 191 | Prolonged partial thromboplastin time (HP:0003645) | 1.62370558 |
| 192 | Glomerulosclerosis (HP:0000096) | 1.62207743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.97115518 |
| 2 | MAP3K12 | 3.93001604 |
| 3 | TRIB3 | 3.70323662 |
| 4 | EIF2AK3 | 3.65887716 |
| 5 | TRIM28 | 3.53734648 |
| 6 | MAP3K2 | 2.68176429 |
| 7 | EIF2AK1 | 2.64068774 |
| 8 | FRK | 2.56278181 |
| 9 | SCYL2 | 2.47861392 |
| 10 | BCR | 2.47009914 |
| 11 | PKN2 | 2.43224310 |
| 12 | MAP3K9 | 2.39541371 |
| 13 | KSR2 | 2.37152324 |
| 14 | ERBB3 | 2.15089538 |
| 15 | WNK4 | 2.05307111 |
| 16 | NTRK1 | 2.02710398 |
| 17 | TSSK6 | 1.89324185 |
| 18 | LATS1 | 1.85607474 |
| 19 | MAP4K2 | 1.77220840 |
| 20 | SIK1 | 1.76638631 |
| 21 | INSRR | 1.74310554 |
| 22 | RET | 1.69853807 |
| 23 | STK39 | 1.67757306 |
| 24 | TAOK3 | 1.67031099 |
| 25 | BUB1 | 1.59555488 |
| 26 | RIPK1 | 1.59158058 |
| 27 | MYLK | 1.58657439 |
| 28 | PDK2 | 1.57465828 |
| 29 | FGFR2 | 1.54435651 |
| 30 | PAK6 | 1.53948083 |
| 31 | STK38L | 1.53318058 |
| 32 | PAK3 | 1.53028835 |
| 33 | CAMKK1 | 1.51396931 |
| 34 | PTK6 | 1.50161194 |
| 35 | CAMK1G | 1.49627460 |
| 36 | TESK1 | 1.47500652 |
| 37 | MAP2K4 | 1.46461210 |
| 38 | BMPR2 | 1.45665993 |
| 39 | LIMK1 | 1.45414876 |
| 40 | NTRK3 | 1.44842488 |
| 41 | ALK | 1.42817642 |
| 42 | PDGFRA | 1.39606354 |
| 43 | MARK1 | 1.39074798 |
| 44 | PLK2 | 1.38782917 |
| 45 | SRPK1 | 1.38418211 |
| 46 | WNK1 | 1.35978850 |
| 47 | NUAK1 | 1.31348884 |
| 48 | MAP2K7 | 1.27122537 |
| 49 | CSNK1G3 | 1.26703914 |
| 50 | CAMKK2 | 1.25946387 |
| 51 | BMPR1B | 1.25639504 |
| 52 | SIK3 | 1.24849040 |
| 53 | PRKD3 | 1.23401066 |
| 54 | ADRBK2 | 1.23289726 |
| 55 | ERN1 | 1.21708092 |
| 56 | OXSR1 | 1.21355283 |
| 57 | MAP3K4 | 1.20052645 |
| 58 | EPHB1 | 1.18302918 |
| 59 | CAMK1D | 1.16664053 |
| 60 | ZAK | 1.14363668 |
| 61 | DAPK1 | 1.13806002 |
| 62 | PRKCH | 1.12951421 |
| 63 | PHKG1 | 1.10674608 |
| 64 | PHKG2 | 1.10674608 |
| 65 | PLK3 | 1.08640780 |
| 66 | PBK | 1.08169662 |
| 67 | VRK1 | 1.07657630 |
| 68 | PRKCE | 1.06637357 |
| 69 | FGFR4 | 1.05893123 |
| 70 | PNCK | 1.05509626 |
| 71 | PDPK1 | 1.04244472 |
| 72 | GRK1 | 1.04014638 |
| 73 | TTN | 1.01847850 |
| 74 | STK16 | 1.01722795 |
| 75 | FGFR3 | 1.00913594 |
| 76 | MAP3K1 | 0.99726617 |
| 77 | DAPK2 | 0.98667923 |
| 78 | MINK1 | 0.96453657 |
| 79 | MAPKAPK3 | 0.95133406 |
| 80 | PINK1 | 0.94858384 |
| 81 | PTK2 | 0.93551017 |
| 82 | JAK1 | 0.93464192 |
| 83 | CSNK1G2 | 0.91983038 |
| 84 | PDK4 | 0.90963654 |
| 85 | PDK3 | 0.90963654 |
| 86 | MET | 0.90722673 |
| 87 | PDK1 | 0.89157450 |
| 88 | HIPK2 | 0.88223994 |
| 89 | ACVR1B | 0.87811370 |
| 90 | FER | 0.87475599 |
| 91 | STK11 | 0.86660731 |
| 92 | WNK3 | 0.86358688 |
| 93 | JAK2 | 0.86045502 |
| 94 | SGK3 | 0.85900847 |
| 95 | TYRO3 | 0.85550430 |
| 96 | LMTK2 | 0.85330932 |
| 97 | NEK1 | 0.85231789 |
| 98 | LATS2 | 0.84055430 |
| 99 | MAP3K7 | 0.81648372 |
| 100 | TXK | 0.81028021 |
| 101 | BRSK2 | 0.77637865 |
| 102 | STK38 | 0.76776997 |
| 103 | LRRK2 | 0.74055975 |
| 104 | PRKAA1 | 0.74021631 |
| 105 | PRKD1 | 0.73166537 |
| 106 | SGK494 | 0.73023757 |
| 107 | SGK223 | 0.73023757 |
| 108 | CDK5 | 0.71693674 |
| 109 | BMX | 0.70193339 |
| 110 | MKNK2 | 0.69703307 |
| 111 | CASK | 0.69143059 |
| 112 | STK24 | 0.68058520 |
| 113 | MST1R | 0.67412657 |
| 114 | TEC | 0.66657971 |
| 115 | GSK3A | 0.66528299 |
| 116 | CDK6 | 0.64460080 |
| 117 | STK3 | 0.64227870 |
| 118 | PDGFRB | 0.63909388 |
| 119 | PAK4 | 0.63839726 |
| 120 | MAP2K1 | 0.63258414 |
| 121 | TAOK1 | 0.63179027 |
| 122 | GRK7 | 0.62896895 |
| 123 | MAP3K5 | 0.62273315 |
| 124 | KSR1 | 0.62174832 |
| 125 | EEF2K | 0.61812663 |
| 126 | SIK2 | 0.60451526 |
| 127 | BCKDK | 0.60372364 |
| 128 | ILK | 0.60045118 |
| 129 | TESK2 | 0.59693619 |
| 130 | CSNK1A1L | 0.58563502 |
| 131 | EPHA4 | 0.58160301 |
| 132 | GRK5 | 0.55731096 |
| 133 | IKBKB | 0.51884883 |
| 134 | PIM2 | 0.50016281 |
| 135 | CAMK2A | 0.49604310 |
| 136 | EGFR | 0.49506524 |
| 137 | ERBB4 | 0.48651643 |
| 138 | MARK3 | 0.48635909 |
| 139 | PRKACG | 0.47348440 |
| 140 | PRKAA2 | 0.46509853 |
| 141 | STK10 | 0.46320838 |
| 142 | FGFR1 | 0.44874207 |
| 143 | CAMK2G | 0.44179087 |
| 144 | EIF2AK2 | 0.43995674 |
| 145 | CSNK1G1 | 0.43677608 |
| 146 | EPHA3 | 0.42855564 |
| 147 | CAMK2D | 0.41980410 |
| 148 | YES1 | 0.41862649 |
| 149 | CAMK2B | 0.41365202 |
| 150 | IKBKE | 0.41111620 |
| 151 | FYN | 0.40908109 |
| 152 | MTOR | 0.40575191 |
| 153 | PRKCG | 0.40330876 |
| 154 | SGK1 | 0.39550771 |
| 155 | MAP3K14 | 0.38852585 |
| 156 | MAPK13 | 0.38424956 |
| 157 | TLK1 | 0.38368244 |
| 158 | IGF1R | 0.36337896 |
| 159 | MUSK | 0.36152181 |
| 160 | TNIK | 0.35890567 |
| 161 | RPS6KA4 | 0.35799984 |
| 162 | ARAF | 0.32220605 |
| 163 | PRKCQ | 0.32013048 |
| 164 | ABL1 | 0.31720710 |
| 165 | PAK1 | 0.29801593 |
| 166 | DAPK3 | 0.29118900 |
| 167 | CCNB1 | 0.28222859 |
| 168 | MKNK1 | 0.27733887 |
| 169 | CDK19 | 0.27211720 |
| 170 | ROCK1 | 0.27056922 |
| 171 | CSF1R | 0.27004924 |
| 172 | CSNK1A1 | 0.26775006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.14191400 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.78936633 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.21574735 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.08091410 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.69705220 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.64121138 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43477523 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.34262818 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11324188 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.05777283 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98067664 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.92055026 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.91388859 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.90324460 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85168077 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.75416945 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70715918 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.70557862 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.69949925 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.68860776 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68570543 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.67969789 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63415006 |
| 24 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.59979565 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.59805582 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59230769 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54830330 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51001023 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50068479 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.49835704 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47302807 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45627418 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.36807777 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31938254 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30670887 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28821878 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26379745 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25472664 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22430512 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.22427185 |
| 41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21093771 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.20936984 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20395929 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17694358 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16107663 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15873140 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12584940 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11848128 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07654360 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06888738 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06289528 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05509740 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.03904934 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03866147 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02371987 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01049199 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00841054 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99573794 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.98763545 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97577859 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95468635 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95338178 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95111509 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.94912018 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93682301 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91841459 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89272652 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88722442 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87934675 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87204624 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86243743 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85616810 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85400343 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84968031 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84589437 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84281915 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.83770368 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83759816 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83293841 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82729111 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.82678409 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81777336 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.81581722 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80871007 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80692569 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79421659 |
| 87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77866338 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76879358 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.76706283 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76515621 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76290507 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75810941 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74893103 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.74844233 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73700698 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73615196 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71814987 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.70831708 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70423569 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69871704 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69369972 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69014885 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68331882 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.67981822 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.67897092 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67890267 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67368248 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66826876 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66750285 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.66646685 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66527281 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66199231 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65448022 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65027063 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.64887915 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63083121 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63065176 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.62840277 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62631600 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62287849 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61801352 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60671675 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58953193 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58772654 |
| 125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58241580 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.57466703 |
| 127 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56897098 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55132279 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53307796 |
| 130 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52346221 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52037376 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51911038 |
| 133 | Mismatch repair_Homo sapiens_hsa03430 | 0.51670056 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51150733 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51091627 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50757044 |
| 137 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.47596596 |
| 138 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46547959 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.45341216 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.45095308 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44621858 |
| 142 | Morphine addiction_Homo sapiens_hsa05032 | 0.44418299 |
| 143 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44087082 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43355369 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42450211 |
| 146 | Phototransduction_Homo sapiens_hsa04744 | 0.41840875 |
| 147 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41319933 |
| 148 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40745643 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40460260 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40204875 |
| 151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39951294 |
| 152 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39311917 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39275613 |
| 154 | Mineral absorption_Homo sapiens_hsa04978 | 0.39138536 |
| 155 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39116835 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.39032152 |
| 157 | Long-term depression_Homo sapiens_hsa04730 | 0.39014213 |
| 158 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38333055 |
| 159 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37144643 |
| 160 | RNA transport_Homo sapiens_hsa03013 | 0.37015581 |
| 161 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34108527 |
| 162 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33719074 |
| 163 | Salmonella infection_Homo sapiens_hsa05132 | 0.33455384 |
| 164 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28623888 |
| 165 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28582158 |
| 166 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28580937 |
| 167 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27771280 |
| 168 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24477431 |

